PropertyValue
?:abstract
  • This issue of the Biomedical Journal acquaints us with the compelling hypothesis that the vascular glycocalyx lies at the intersection of severe COVID-19 risk factors and damages, and the ways used by artificial intelligence to predict interactions between SARS-CoV-2 and human proteins. Furthermore, we explore the antiviral potential of valinomycin and the long list of COVID-19-related clinical trials, and learn how (not) to fix a broken femoral head. Last but not least, we get to enjoy the tale of the cellular oxygen-sensing system as well as the role of the host complement system during Leptospira infection, and learn that SARS-CoV-2 can sometimes come with a pathogenic plus one.
?:creator
?:doi
  • 10.1016/j.bj.2020.10.003
?:doi
?:journal
  • Biomed_J
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/40d33313644fc520b9889d3fbaddfd30d6974364.json; document_parses/pdf_json/70aeebf6399d8349dea7cca94b2269798bbf6595.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7547304.xml.json
?:pmcid
?:pmid
?:pmid
  • 33115641.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Don\'t sugar coat the COVID (only the vasculature)
?:type
?:year
  • 2020-10-10

Metadata

Anon_0  
expand all